Rising prescription drug prices are taking a toll on American families and on the greater economy. This paper explores four alternatives to patent-financed prescription drug research and compares their efficiency.
1611 Connecticut Ave., NWSuite 400
Washington, DC 20009(202) 293-5380
© 2014 Center for Economic and Policy Research